Article by Zachary Stieber from our premium news partners at The Epoch Times.
The agency said that its scientists determined the booster’s benefits, including bolstering protection against virus infection, outweigh its potential risks in the population.
Reviewers analyzed data from Israel, one of the most vaccinated countries in the world, to reach the conclusion.
The dataset from Israel included information on more than 6,300 children 12 through 15 who received a booster dose.
“The data shows there are no new safety concerns following a booster in this population. There were no new cases of myocarditis or pericarditis reported to date in these individuals,” the FDA said in a statement.
Myocarditis and pericarditis are two forms of heart inflammation seen at much higher than expected rates among young people, particularly young men, following vaccination with the Pfizer or Moderna COVID-19 vaccines.
The risk of heart inflammation is actually higher from the vaccines than from COVID-19 itself in young persons, according to some studies.
One study published last month found post-booster inflammation was more prevalent than post-COVID inflammation.
The Centers for Disease Control and Prevention will now take up the authorization and choose whether to recommend boosters to all 12- to 15-year-olds.
The FDA did not post any documents yet on the decision, which came without consulting its expert vaccine advisory panel.
The agency also bypassed the panel in authorizing boosters for 16- and 17-year-olds, and all 18 and older, drawing criticism from some panel members and former FDA officials.
The FDA and booster supporters say additional shots will help restore protection against infection that’s waned against the Omicron variant of the CCP (Chinese Communist Party) virus, which causes COVID-19.
Critics, though, note that Omicron manifests with zero or few symptoms for most who contract it, especially young, healthy people.
Also on Monday, the agency said children aged 5 to 11 who are deemed immunocompromised can get a booster shot of Pfizer’s vaccine.
Unlike older Americans, who must wait at least five months until after their primary series, the youngest age group can get a booster as soon as one month later.
“Based on the FDA’s assessment of currently available data, a booster dose of the currently authorized vaccines may help provide better protection against both the Delta and Omicron variants. In particular, the Omicron variant appears to be slightly more resistant to the antibody levels produced in response to the primary series doses from the current vaccines,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.
“With this in mind, the FDA has extended the range of individuals eligible to receive a booster, shortened the length of time between the completion of the Pfizer primary series for individuals to receive a booster and is authorizing a third protective vaccine dose for some of our youngest and most vulnerable individuals,” he added.
PLEASE Help Us Fight the Good Fight
Today’s Goliath is the Mainstream Media Industrial Complex that brainwashes the masses.
Our mission is very straightforward: To counter the false narratives and nefarious agendas destroying America today. It isn’t easy for obvious reasons; despite incredible growth over the last year we are still a very tiny fish in a huge media pond. But we’re fighting and we will continue to do so, Lord willing, for as long as we possibly can. The battle for America’s present and future is too important for us to back down to the giants that stand in our way.
We need help. I don’t want to say “desperately,” but the need is definitely great. If you have the means, please donate through our GivingFuel page or via PayPal. Your generosity is what keeps these sites running and allows us to get the truth to the masses. We’ve had great success in growing but we know we can do more with your assistance.
Thank you, and God Bless!
All ORIGINAL content on this site is © 2021 NOQ Report. All REPUBLISHED content has received direct or implied permission for reproduction.
With that said, our content may be reproduced and distributed as long as it has a link to the original source and the author is credited prominently. We don’t mind you using our content as long as you help out by giving us credit with a prominent link. If you feel like giving us a tip for the content, we will not object!
JD Rucker – EIC